CLINICAL TRIALS PROFILE FOR DETROL LA

All Clinical Trials for Detrol La

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00143481 ↗	Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women	Completed	Pfizer	Phase 4	2005-03-01	The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00143481 ↗	Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2005-03-01	The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00147654 ↗	Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	Completed	Pfizer	Phase 4	2004-11-01	The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00147654 ↗	Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2004-11-01	The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00174798 ↗	MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.	Completed	Sanofi	Phase 2	2005-05-01	To evaluate the safety and efficacy of SSR240600C versus placebo on clinical and cystometric parameters in patients with OAB and UUI.

Clinical Trial Conditions for Detrol La

Condition Name

Condition Name for Detrol La
Intervention	Trials
Urinary Incontinence	5
Overactive Bladder	4
Urinary Bladder, Overactive	2
Overactive Bladder (OAB)	2

Condition MeSH

Condition MeSH for Detrol La
Intervention	Trials
Urinary Bladder, Overactive	11
Urinary Incontinence	7
Enuresis	7
Urinary Bladder Neck Obstruction	2

Clinical Trial Locations for Detrol La

Trials by Country

Trials by Country for Detrol La
Location	Trials
United States	186
Canada	11
South Africa	4
United Kingdom	4
Mexico	3

Trials by US State

Trials by US State for Detrol La
Location	Trials
California	10
New York	9
Florida	8
Arizona	8
Texas	8

Clinical Trial Progress for Detrol La

Clinical Trial Phase

Clinical Trial Phase for Detrol La
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	3
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Detrol La
Clinical Trial Phase	Trials
Completed	15
Terminated	1

Clinical Trial Sponsors for Detrol La

Sponsor Name

Sponsor Name for Detrol La
Sponsor	Trials
Pfizer	8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	5
Astellas Pharma Inc	2

Sponsor Type

Sponsor Type for Detrol La
Sponsor	Trials
Industry	20
Other	4